In The Good, The Bad, and The Ugly: One analyst's buy rating on Alibaba stock; the government's rough housing numbers; and the Apple CEO's privacy push» Read More
Boris Schlossberg, BK Asset Management, discusses the impact of Scotland's vote on the British pound and euro. Also Dan Dicker, The Street.com, shares his thoughts on oil prices.
CNBC's Jon Fortt and Jeffrey Sonnenfeld, Yale School of Management, discuss the two CEOs named to replace Larry Ellison at the helm of Oracle; Mark Hurd and Safra Catz.
This is a Band-aid solution, says Jeffrey Sonnenfeld, Yale School of Management, providing insight into Oracle's management shakeup and other major changes at top-tier companies, including IBM. And CNBC's Jon Fortt, shares insight.
Die-hard fans are waiting on long line to get their hands on the iPhone 6 for the first time, reports CNBC's Josh Lipton.
CNBC's Michelle Caruso-Cabrera reports the results of Scotland's vote on independence.
CNBC's Kayla Tausche reports the latest details on Alibaba's public debut on the NYSE.
Marriott is offering a solution for those who can't afford to get away... a virtual trip.
Ronald Josey, JMP Securities senior analyst, discusses Yahoo's stake in Alibaba and explains why it may be less of a catalyst than investors think.
CNBC's Eunice Yoon reports on Alibaba's influence on Chinese culture. Also Yoon takes a look at the latest developments in the Glaxo bribery case in China.
Marc Farber, "Gloom, Boom & Doom" publisher, shares his thoughts on how inflation and commodity prices are likely to impact purchasing power.
Marc Faber, "Gloom, Boom & Doom" publisher, explains how levered markets will impair emerging market growth.
Marc Faber, "Gloom, Boom & Doom" publisher, warns there will be a problem if asset markets begin to perform poorly when rates begin to rise.
Apple's new iPhone 6 and 6 Plus smartphones go on sale Friday. The new phones are larger and thinner than previous models, reports CNBC's Morgan Brennan.
The biggest IPO of the year will commence trading on Friday, reports CNBC's Kayla Tausche with the update on Alibaba's public debut on the NYSE.
The votes are in and Scots have decided to stay with the United Kingdom, reports CNBC's Michelle Caruso-Cabrera.
No, Alibaba doesn't actually cure cancer; however, you would think so as some traders say it's lifting stocks ahead of its IPO tomorrow.
Showing up to work high? You're not alone. A new report has found nearly 1 in 10 Americans are showing up to work high on marijuana. The Squawk Box crew discusses the story.
With plenty of vacant homes, there’s just not enough demand to necessitate building more new homes. So why are they being built?
There are several reasons I am optimistic that Alibaba—at whatever price—will open to the upside and stay there.
CNBC's Jim Cramer explains why he doesn't want to see Alibaba open above $80 per share when it comes public on Friday.
Get the best of CNBC in your inbox